| Ident. | Authors (with country if any) | Title |
|---|
| 000003 (2013) |
An Chan [Canada] ; Jennifer. Tetzlaff [Canada] ; Peter. G [Danemark] ; Douglas. Altman [Royaume-Uni] ; Howard Mann [États-Unis] ; Jesse. Berlin [États-Unis] ; Kay Dickersin [États-Unis] ; Asbj Hr [Danemark] ; Kenneth. Schulz [États-Unis] ; Wendy. Parulekar [Canada] ; Karmela Krleža [Canada] ; Andreas Laupacis [Canada] ; David Moher [Canada] | SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials |
| 000005 (2013) |
Franziska Maier [Allemagne] ; Catharine. Lewis [Allemagne] ; Nina Horstkoetter [Allemagne] ; Carsten Eggers [Allemagne] ; Elke Kalbe [Allemagne] ; Mohammad Maarouf [Allemagne] ; Jens Kuhn [Allemagne] ; Mateusz Zurowski [Canada] ; Elena Moro [France] ; Christiane Woopen [Allemagne] ; Lars Timmermann [Allemagne] | Patients’ expectations of deep brain stimulation, and subjective perceived outcome related to clinical measures in Parkinson's disease: a mixed-method approach |
| 000006 (2013) |
Connie Marras [Canada] ; Anthony Lang [Canada] | Parkinson's disease subtypes: lost in translation? |
| 000028 (2011) |
Pettarusp. Wadia [Canada] ; Gamaliel Tan [Canada] ; Renato. Munhoz [Canada] ; Susan. Fox [Canada] ; Stephen. Lewis [Canada] ; Anthony. Lang [Canada] | Surgical correction of kyphosis in patients with camptocormia due to Parkinson's disease: a retrospective evaluation |
| 000046 (2011) |
Pascal Van [Canada] ; Catriona Steele [Canada] ; Anthony Lang [Canada] | Tongue control for swallowing in Parkinson's disease: Effects of age, rate, and stimulus consistency |
| 000102 (2011) |
Wassilios Meissner [France] ; Mark Frasier [États-Unis] ; Thomas Gasser [Allemagne] ; Christopher Goetz [États-Unis] ; Andres Lozano [Canada] ; Paola Piccini [Royaume-Uni] ; José Obeso [Espagne] ; Olivier Rascol [France] ; Anthony Schapira [Royaume-Uni] ; Valerie Voon [Royaume-Uni] ; David Weiner [États-Unis] ; François Tison [France] ; Erwan Bezard [France] | Priorities in Parkinson's disease research |
| 000106 (2011) |
Connie Marras [Canada] ; Michael Mcdermott [États-Unis] ; Ken Marek [États-Unis] ; Paula Rochon [Canada] ; Gary Naglie [Canada] ; Caroline Tanner [États-Unis] ; Alice Rudolph [États-Unis] ; Ira Shoulson [États-Unis] ; Anthony Lang [Canada] | Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts |
| 000122 (2011) |
Cristina Sampaio [Portugal] ; Juliana Bronzova [Pays-Bas] ; Robert Hauser [États-Unis] ; Anthony Lang [Canada] ; Olivier Rascol [France] ; Serge Van [Pays-Bas] ; And Theeuwes [Pays-Bas] | Pardoprunox in early Parkinson's disease: Results from 2 large, randomized double‐blind trials |
| 000145 (2011) |
Arpan Mehta [Canada, Royaume-Uni] ; Susan Fox [Canada] ; Mark Tarnopolsky [Canada] ; Grace Yoon [Canada] | Mitochondrial mimicry of multiple system atrophy of the cerebellar subtype |
| 000151 (2011) |
Olivier Rascol [France] ; Andres Lozano [Canada] ; Matthew Stern [États-Unis] ; Werner Poewe [Autriche] | Milestones in Parkinson's disease therapeutics |
| 000178 (2011) |
Helen Bronte [États-Unis] ; Takaomi Taira [Japon] ; Francesc Valldeoriola [Espagne] ; Marcello Merello [Argentine] ; William Marks [États-Unis] ; Alberto Albanese [Italie] ; Susan Bressman [États-Unis] ; And Moro [Canada] | Inclusion and exclusion criteria for DBS in dystonia |
| 000210 (2011) |
Andreas Kupsch [Allemagne] ; Michele Tagliati [États-Unis] ; Marie Vidailhet [France] ; Tipu Aziz [Royaume-Uni] ; Paul Krack [France] ; Elena Moro [Canada] ; Joachim Krauss [Allemagne] | Early postoperative management of DBS in dystonia: Programming, response to stimulation, adverse events, medication changes, evaluations, and troubleshooting |
| 000423 (2010) |
Galit Kleiner [Canada] ; Andres Lozano [Canada] ; Elena Moro [Canada] ; Yu Poon [Canada] ; Anthony Lang [Canada] | Long‐term effect of unilateral pallidotomy on levodopa‐induced dyskinesia |
| 000433 (2010) |
Fabrizio Stocchi [Italie] ; Olivier Rascol [France] ; Karl Kieburtz [États-Unis] ; Werner Poewe [Autriche] ; Joseph Jankovic [États-Unis] ; Eduardo Tolosa [Espagne] ; Paulo Barone [Italie] ; Anthony Lang [Canada] ; C Olanow [Italie, États-Unis] | Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE‐PD study |
| 000485 (2010) |
Alberto Espay [États-Unis] ; Jennifer Vaughan [États-Unis] ; Connie Marras [Canada] ; Rob Fowler [Canada] ; Mark Eckman [États-Unis] | Early versus delayed bilateral subthalamic deep brain stimulation for parkinson's disease: A decision analysis |
| 000490 (2010) |
Amitabh Gupta [Canada] ; Anthony Lang [Canada] | Drug‐induced cranial myoclonus |
| 000492 (2010) |
Juliana Bronzova [Pays-Bas] ; Cristina Sampaio [Portugal] ; Robert Hauser [États-Unis] ; Anthony Lang [Canada] ; Olivier Rascol [France] ; Ad Theeuwes [Pays-Bas] ; Serge Van [Pays-Bas] ; Guus Van [Pays-Bas] | Double‐blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease |
| 000521 (2010) |
Susanne Schneider [Royaume-Uni, Allemagne] ; Anthony Lang [Canada] ; Elena Moro [Canada] ; Benedikt Bader [Allemagne] ; Adrian Danek [Allemagne] ; Kailash Bhatia [Royaume-Uni] | Characteristic head drops and axial extension in advanced chorea‐acanthocytosis |
| 000524 (2010) |
Steven Schwid [États-Unis] ; Janice Bausch [États-Unis] ; David Oakes [États-Unis] ; Lynn Schuchter [États-Unis] ; Caroline Tanner [États-Unis] ; Misser Forrest [Danemark] ; Anthony Lang [Canada] ; Ira Shoulson [États-Unis] | Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease |
| 000561 (2010) |
Anette Schrag [Royaume-Uni] ; Shamira Sheikh [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Andrew Lees [Royaume-Uni] ; Caroline Selai [Royaume-Uni] ; Chris Mathias [Royaume-Uni] ; Irene Litvan [États-Unis] ; Anthony Lang [Canada] ; James Bower [États-Unis] ; David Burn [Royaume-Uni] ; Philip Low [États-Unis] ; Marjan Jahanshahi [Royaume-Uni] | A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy |
| 000732 (2009) |
Andrew Evans [Australie] ; Antonio Strafella [Canada] ; Daniel Weintraub [États-Unis] ; Mark Stacy [États-Unis] | Impulsive and compulsive behaviors in Parkinson's disease |
